ADVANCED ENZYME TECHNOLOGIES
Back to All Ratios
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 15.24 | 15.40 | 12.42 | 14.20 | 16.11 |
What is the latest Cash Earnings per Share (CEPS) ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 15.24 |
| Mar2024 | 15.40 |
| Mar2023 | 12.42 |
| Mar2022 | 14.20 |
| Mar2021 | 16.11 |
How is Cash Earnings per Share (CEPS) of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 15.24 | -1.04 | |
| Mar2024 | 15.4 | 23.99 | |
| Mar2023 | 12.42 | -12.54 | |
| Mar2022 | 14.2 | -11.86 | |
| Mar2021 | 16.11 | - | |
Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹2,857.9 Cr | -4% | -15.8% | -10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -4% |
-15.8% |
-10.7% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses